Following on from studies conducted in India and Sierra Leone, the ICAN team released the report of the campaign costing study conducted in Nigeria as part of efforts to standardize campaign costing.
The study in Nigeria aimed to estimate the delivery cost of the yellow fever campaigns in Anambra, Katsina, and Rivers states, with Meningitis A vaccines also being co-delivered as part of the campaign in Anambra. The study estimated the full financial and economic costs of the campaigns and costs were collected at ward, LGA, and state-level, and from federal level government offices and development partners. Costs were aggregated to estimate the volume and sampling probability-weighted average cost per dose delivered, and the total cost of the campaign.
Per dose delivered, the financial delivery cost was US$0.29 in Rivers, US$0.34 in Katsina, and US$0.35 in Anambra, mostly driven by per diem and allowances, vaccine injection supplies, and transport and fuel costs. The economic cost per dose delivered was US$0.62 in Katsina, US$0.71 in Anambra and US$0.85 in Rivers, and paid and volunteer labor were the key cost drivers among economic cost.